Hosted on MSN5d
Scotiabank Initiates Coverage of Viking Therapeutics (VKTX) with Sector Outperform Recommendation
Fintel reports that on February 13, 2025, Scotiabank initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Sector ...
Scotiabank starts Viking Therapeutics at Outperform, sees attractive entry point
As previously reported, Scotiabank analyst George Farmer initiated coverage of Viking Therapeutics (VKTX) with an Outperform rating and $102 ...
H.C. Wainwright Sticks to Their Buy Rating for Viking Therapeutics (VKTX)
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target ...
ETF Daily News3d
Viking Therapeutics (NASDAQ:VKTX) Research Coverage Started at Scotiabank
VKTX stock opened at $30.48 on Thursday. Viking Therapeutics has a fifty-two week low of $28.64 and a fifty-two week high of $99.41. The business’s 50-day moving average is $37.97 and its two ...
SchaeffersResearch.com5d
3 Weight-Loss Drug Stocks to Watch
Weight-loss drugs have been popular over the past couple of years, and Hims & Hers Health Inc (NYSE:HIMS), Novo Nordisk A/S ( NYSE:NVO), and Viking Therapeutics Inc (NASDAQ:VKTX) are among the most ...